Smart dosing may help diabetic liver patients control sugar and pain
NCT ID NCT07439536
First seen Mar 19, 2026 · Last updated Apr 29, 2026 · Updated 7 times
Summary
This study tested whether using a computer model to adjust doses of two diabetes and nerve pain drugs (sitagliptin and duloxetine) works better in patients with liver cirrhosis. 64 adults with cirrhosis, diabetes, and nerve pain took part. The goal was to improve blood sugar control and reduce pain while monitoring side effects. The approach aims to make treatment safer and more effective for this complex group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS WITH DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kafr El-Sheikh University
Cairo, Kafrelsheikh, 33511, Egypt
Conditions
Explore the condition pages connected to this study.